BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koroknai V, Szász I, Hernandez-Vargas H, Fernandez-Jimenez N, Cuenin C, Herceg Z, Vízkeleti L, Ádány R, Ecsedi S, Balázs M. DNA hypermethylation is associated with invasive phenotype of malignant melanoma. Exp Dermatol 2020;29:39-50. [PMID: 31602702 DOI: 10.1111/exd.14047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Anestopoulos I, Kyriakou S, Tragkola V, Paraskevaidis I, Tzika E, Mitsiogianni M, Deligiorgi M, Petrakis G, Trafalis D, Botaitis S, Giatromanolaki A, Koukourakis M, Franco R, Pappa A, Panayiotidis M. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacology & Therapeutics 2022;240:108301. [DOI: 10.1016/j.pharmthera.2022.108301] [Reference Citation Analysis]
2 Rubanov A, Berico P, Hernando E. Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies. Cancers 2022;14:5858. [DOI: 10.3390/cancers14235858] [Reference Citation Analysis]
3 Deng Y, Zhang X, Li D, Xu H. Pan-cancer analysis of the oncogenic effect of SorCS1 in human tumors and its correlation with LRP2 protein.. [DOI: 10.21203/rs.3.rs-2186632/v1] [Reference Citation Analysis]
4 Liu Z, Liu H, Wang Y, Li Z. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma. BMC Gastroenterol 2022;22:435. [PMID: 36241983 DOI: 10.1186/s12876-022-02510-8] [Reference Citation Analysis]
5 Karami Fath M, Azargoonjahromi A, Soofi A, Almasi F, Hosseinzadeh S, Khalili S, Sheikhi K, Ferdousmakan S, Owrangi S, Fahimi M, Zalpoor H, Nabi Afjadi M, Payandeh Z, Pourzardosht N. Current understanding of epigenetics role in melanoma treatment and resistance. Cancer Cell Int 2022;22:313. [PMID: 36224606 DOI: 10.1186/s12935-022-02738-0] [Reference Citation Analysis]
6 Sivanantham S, Saravanan M, Sharma N, Shrinivasan J, Raja R. Morphology of inner cell mass: a better predictive biomarker of blastocyst viability. PeerJ 2022;10:e13935. [DOI: 10.7717/peerj.13935] [Reference Citation Analysis]
7 Bustos MA, Hoon DSB. Prognostic Utility of CpG Island Hypermethylated Phenotype in Early-Stage Invasive Primary Melanomas. J Invest Dermatol 2022;142:1770-2. [PMID: 35031134 DOI: 10.1016/j.jid.2021.12.013] [Reference Citation Analysis]
8 Rius FE, Papaiz DD, Azevedo HFZ, Ayub ALP, Pessoa DO, Oliveira TF, Loureiro APM, Andrade F, Fujita A, Reis EM, Mason CE, Jasiulionis MG. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival. Clin Epigenetics 2022;14:68. [PMID: 35606887 DOI: 10.1186/s13148-022-01291-x] [Reference Citation Analysis]
9 Benboubker V, Boivin F, Dalle S, Caramel J. Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma. Front Immunol 2022;13:873116. [PMID: 35432344 DOI: 10.3389/fimmu.2022.873116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fu X, Wei S, Wang T, Fan H, Zhang Y, Costa CD, Brandner S, Yang G, Pan Y, He Y, Li N. Research Status of the Orphan G Protein Coupled Receptor 158 and Future Perspectives. Cells 2022;11:1334. [DOI: 10.3390/cells11081334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Koroknai V, Szász I, Jámbor K, Balázs M. Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines. Int J Mol Sci 2022;23:2644. [PMID: 35269787 DOI: 10.3390/ijms23052644] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Liu X, Yang P, Han L, Zhou Q, Qu Q, Shi X. The ncRNA-Mediated Overexpression of Ferroptosis-Related Gene EMC2 Correlates With Poor Prognosis and Tumor Immune Infiltration in Breast Cancer. Front Oncol 2021;11:777037. [PMID: 34956895 DOI: 10.3389/fonc.2021.777037] [Reference Citation Analysis]
13 van Andel MM, Groenink M, van den Berg MP, Timmermans J, Scholte AJHA, Mulder BJM, Zwinderman AH, de Waard V. Genome-wide methylation patterns in Marfan syndrome. Clin Epigenetics 2021;13:217. [PMID: 34895303 DOI: 10.1186/s13148-021-01204-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Aleotti V, Catoni C, Poggiana C, Rosato A, Facchinetti A, Scaini MC. Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. Cancers (Basel) 2021;13:6217. [PMID: 34944843 DOI: 10.3390/cancers13246217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Chhabra G, Singh CK, Guzmán-Pérez G, Ndiaye MA, Iczkowski KA, Ahmad N. Anti-melanoma effects of concomitant inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL mice. J Invest Dermatol 2021:S0022-202X(21)02223-5. [PMID: 34597611 DOI: 10.1016/j.jid.2021.08.434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Scattone NV, Epiphanio TMF, Caddrobi KG, Ferrão JSP, Hernandez-Blazquez FJ, Loureiro APM, Massoco CO, Dagli MLZ. Quantification of Global DNA Methylation in Canine Melanotic and Amelanotic Oral Mucosal Melanomas and Peripheral Blood Leukocytes From the Same Patients With OMM: First Study. Front Vet Sci 2021;8:680181. [PMID: 34504885 DOI: 10.3389/fvets.2021.680181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Andersen B, Millar S. Skin epigenetics. Exp Dermatol 2021;30:1004-8. [PMID: 34223679 DOI: 10.1111/exd.14418] [Reference Citation Analysis]
18 Li M, Wang Z, Zhu L, Shui Y, Zhang S, Guo W. Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20210328. [PMID: 33834191 DOI: 10.1042/BSR20210328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Işik S, Töre T, Canaz F, Özen H, Erzurumluoğlu E, Çilingir O, Artan S, Durak Aras B. Malign Melanomlar ile Melanositik Nevüs Ayrımında EGFR, CCND1 ve RREB1 Genlerini Hedef Alan FISH Testinin Yeri. OSMANGAZİ JOURNAL OF MEDICINE 2021. [DOI: 10.20515/otd.886981] [Reference Citation Analysis]
20 Diefenbach RJ, Lee JH, Rizos H. Methylated circulating tumor DNA as a biomarker in cutaneous melanoma. Melanoma Manag 2020;7:MMT46. [PMID: 32922728 DOI: 10.2217/mmt-2020-0010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]